GSK583 |
GSK583 : ATP competitive inhibitor of RIPK2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| RIPK2 |
|
|
ATP competitive
200 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - RIPK3 16 nM
Potency Assay Off-Target:
RIPK3: A fluorescent polarization based binding assay was developed to quantitate interaction of no ...
Selectivity Assessment Description:
hERG: Electrophysiology; Whole cell voltage clamp technique permits investigation of the physiolo ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
Cellular selectivity of GSK583 was evaluated in primary human monocytes. In the presence of 1 μM GSK ...
Potency Cellular
In Vitro
RIPK2
Mode of Action: ATP competitive
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.6b00211
In Vivo Validations
Rat, Mouse
Dose: 2 mg/kg oral, 1 mg/kg IV crossover (mouse and rat)
Route of delivery:
Intravenous, Oral
Plasma half life:
3.1 h (rat), 2.1 h (mouse)
Systemic clearance:
15 mL/min/kg (rat), 13 mL/min/kg (mouse)
DOI Reference: 10.1021/acs.jmedchem.6b00211
Chemical Information
| Molecular Formula | C20H19FN4O2S |
| SMILEs | CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1 |
| InChI | InChI=1S/C20H19FN4O2S/c1-20(2,3)28(26,27)13-5-7-16-14(11-13)17(8-9-22-16)23-19-15-10-12(21)4-6-18(15)24-25-19/h4-11H,1-3H3,(H2,22,23,24,25) |
| Molecular weight | 398.12 Da |
| AlogP | 4.566000000000003 |
| HBond acceptors | 6 |
| HBond donors | 2 |
| Atoms | 47 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.